Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Bicycle Therapeutics PLC changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 105 | 1 | 97 | −7 |
| Shares | 40.4M | 20.8K | 41.9M | +1.47M (+3.6%) |
| Value | $915.3M | $471.3K | $586.5M | −$328.3M (−35.9%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Bicycle Therapeutics PLC at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Siren, L.L.C. | 1,839,398 | $25.8M | 1.14% |
| Long Focus Capital Management, LLC | 543,092 | $7.60M | 0.58% |
| Pinnacle Associates Ltd | 226,742 | $3.17M | 0.04% |
| Millennium Management LLC | 176,757 | $2.47M | 0.00% |
| Caption Management, LLC | 163,076 | $2.28M | 0.09% |
| Springhill Fund Asset Management (HK) Co Ltd | 116,400 | $1.63M | 2.65% |
| EntryPoint Capital, LLC | 43,873 | $614.2K | 0.26% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 4,043 | $56.6K | 0.00% |
| GF Fund Management Co. Ltd. | 924 | $12.9K | 0.00% |
| Group One Trading, L.P. | 466 | $6.52K | 0.00% |
| R Squared Ltd | 180 | $2.52K | 0.00% |
| Caitong International Asset Management Co., Ltd | 148 | $2.07K | 0.00% |
| AdvisorNet Financial, Inc | 100 | $1.40K | 0.00% |
| TD Waterhouse Canada Inc. | 100 | $1.40K | 0.00% |
| Steward Partners Investment Advisory, LLC | 10 | $140 | 0.00% |
| SBI Securities Co., Ltd. | 7 | $98 | 0.00% |
Sold out (23)
Institutions that held Bicycle Therapeutics PLC at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Polar Capital Holdings Plc | 1,002,780 | $22.7M |
| First Light Asset Management, LLC | 967,006 | $21.9M |
| Camber Capital Management LP | 915,000 | $20.7M |
| Logos Global Management LP | 500,000 | $11.3M |
| Marshall Wace, LLP | 330,258 | $7.47M |
| Kennedy Capital Management, Inc. | 261,067 | $5.91M |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 190,200 | $4.30M |
| Fairmount Funds Management LLC | 123,538 | $2.80M |
| Granahan Investment Management Inc | 96,916 | $2.19M |
| Soleus Capital Management, L.P. | 78,315 | $1.77M |
| L & S Advisors Inc | 59,735 | $1.35M |
| Gilder Gagnon Howe & Co LLC | 43,904 | $993.5K |
| AlphaCentric Advisors LLC | 37,500 | $848.6K |
| Davenport & Co LLC | 20,650 | $467.3K |
| NEOS Investment Management LLC | 17,652 | $399.5K |
| Nomura Holdings Inc | 13,095 | $296.3K |
| Jump Financial, LLC | 11,600 | $262.5K |
| Two Sigma Advisers, LP | 11,300 | $255.7K |
| Pathstone Holdings, LLC | 10,228 | $231.5K |
| Simplex Trading, LLC | 771 | $17.0K |
| Macroview Investment Management LLC | 126 | $2.85K |
| Clear Street Markets LLC | 97 | $2.00K |
| Wells Fargo & Company | 30 | $679 |
Not filed for Q4 2024 yet (1)
Institutions that held Bicycle Therapeutics PLC at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| PEAK6 Investments LLC | 20,826 | $471.3K |